Literature DB >> 29020491

Ocular Syphilis: An Update.

Parthopratim Dutta Majumder1, Elizabeth J Chen2, Janika Shah3, Dawn Ching Wen Ho2, Jyotirmay Biswas1, Leo See Yin4, Vishali Gupta5, Carlos Pavesio6, Rupesh Agrawal2,6,7.   

Abstract

This review aims to provide an update on the clinical presentation, diagnosis, and treatment of ocular syphilis. While ocular syphilis is not a new phenomenon, recent resurgence in the incidence of overall syphilis, particularly among HIV-positive individuals, has sparked a new interest in an old disease. The challenge of ocular syphilis is manifold: firstly, it manifests in a spectrum of ways that can occur at any stage of the disease, with the most common finding being panuveitis. It may occur as early as 6 weeks after transmission and may be the only presenting feature of systemic syphilis; secondly, the relationship between HIV and syphilis has been established, as primary syphilis facilitates HIV transmission and HIV may modify the natural course of syphilis, increasing the propensity of the disease to progress to neurosyphilis. The authors present the latest updates to the changing landscape of ocular syphilis.

Entities:  

Keywords:  Chorioretintis; HIV; Masquerade; Ocular syphilis; Uveitis

Mesh:

Substances:

Year:  2017        PMID: 29020491     DOI: 10.1080/09273948.2017.1371765

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  9 in total

1.  Triple trouble: A case of retinochoroiditis in a patient with syphilis, tuberculosis, and human immunodeficiency virus infection.

Authors:  Neethu Latif; M K Janani; Poongulali Selvamuthu; Parthopratim Dutta Majumder
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

2.  Spirochetal uveitis: Spectrum of clinical manifestations, diagnostic and therapeutic approach, final outcome and epidemiological data.

Authors:  Dimitrios Kalogeropoulos; Ioannis Asproudis; Maria Stefaniotou; Marilita Moschos; Constantina Gartzonika; Ioannis Bassukas; Spiros Konitsiotis; Haralampos Milionis; Georgios Gaitanis; Konstantinos Malamos; Chris Kalogeropoulos
Journal:  Int Ophthalmol       Date:  2021-07-23       Impact factor: 2.031

3.  Commentry: Ocular coinfections in human immunodeficiency virus infection-What is so different?

Authors:  S Balamurugan; Bharat Gurnani; Kirandeep Kaur
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

4.  Choroidal neovascularization secondary to ocular syphilis.

Authors:  Marta Paula Świerczyńska; Lech Stanisław Sedlak; Marta Anna Nowak; Dorota Wyględowska-Promieńska
Journal:  Rom J Ophthalmol       Date:  2021 Oct-Dec

5.  The multifaceted presentation of syphilitic chorioretinitis examined by multimodal imaging: A case series.

Authors:  Lorenzo Ferro Desideri; Raffaella Rosa; Donatella Musetti; Aldo Vagge; Antonio Vena; Matteo Bassetti; Carlo Enrico Traverso; Massimo Nicolò
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-17

6.  A Rare Presentation of Undiagnosed Systemic Syphilis: A Case Report and Review of Literature.

Authors:  Ariel Ruiz de Villa; Asad A Haider; Leora Frimer; Amina Lleshi; Yvette Bazikian
Journal:  Cureus       Date:  2022-08-12

7.  Pyramidal Inflammatory Deposits of the Retinal Pigment Epithelium and Outer Retina in Ocular Syphilis.

Authors:  Katherine S Hu; Albert T Vitale; Akbar Shakoor; Marissa Larochelle; Therese Sassalos; Susan G Elner; Thiran Jayasundera; Christopher D Conrady
Journal:  Ophthalmol Retina       Date:  2021-07-02

8.  The Eye as a Window to Systemic Infectious Diseases: Old Enemies, New Imaging.

Authors:  Vittorio Pirani; Paolo Pelliccioni; Serena De Turris; Alessandro Rosati; Alessandro Franceschi; Claudia Cesari; Michele Nicolai; Cesare Mariotti
Journal:  J Clin Med       Date:  2019-09-05       Impact factor: 4.241

9.  The Great Masquerader: Syphilis Mimicking Papilledema and Traction Alopecia.

Authors:  Michelle A McNally; Angela Murira; Christen M Dillard; Gabriel Aisenberg
Journal:  Cureus       Date:  2020-03-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.